Cargando…

Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?

Granulocyte-monocyte apheresis is a relatively new therapy that has been proposed, sometimes with controversial results, for the treatment of inflammatory bowel disease, particularly ulcerative colitis. The aim of the present study was to perform a thorough review of the literature on the applicatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vecchi, Maurizio, Vernia, Piero, Riegler, Gabriele, D’Incà, Renata, Annese, Vito, Bagnoli, Siro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541711/ https://www.ncbi.nlm.nih.gov/pubmed/23323022 http://dx.doi.org/10.2147/CEG.S33275

Ejemplares similares

Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study
por: Grazie, Marco Le, et al.
Publicado: (2021)

PPARγ in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2012)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
por: Alenazi, Aqeel M., et al.
Publicado: (2023)

Where Should Typhus Be Treated?
por: Fox, Edward Long
Publicado: (1866)

Where Should Papers Be Published?
Publicado: (1891)

Respondent driven sampling—where we are and where should we be going?
por: White, Richard G, et al.
Publicado: (2012)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

COVID-19 Vaccination. Where Are We and Where Should We Go?
por: Peña-Otero, David
Publicado: (2022)

Neovascularization of engineered tissues for clinical translation: Where we are, where we should be?
por: Nazeer, Muhammad Anwaar, et al.
Publicado: (2021)

Simulation training in hand surgery — where are we now and where should we be?
por: Harsten, Rebecca, et al.
Publicado: (2021)

Micronutrients in Maternal and Infant Health: Where We Are and Where We Should Go
por: Yu, Yunxian
Publicado: (2023)

Where Should Hospitalist Programs be Housed?
por: McGinn, Thomas, et al.
Publicado: (2008)

Understanding where the supersymmetry threshold should be
por: Zichichi, Antonino
Publicado: (1992)

Where Should the Surgical Neonates be Nursed?
por: Ramji, Siddarth, et al.
Publicado: (2012)

Systematic Reviews in Occupational Health and Safety: where are we and where should we go?
por: Verbeek, Jos, et al.
Publicado: (2019)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario
por: Zingone, Fabiana, et al.
Publicado: (2020)

Where should a magnetic field be measured?
por: Wind, H
Publicado: (1969)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Functional genomics and rheumatoid arthritis: where have we been and where should we go?
por: Jarvis, James N, et al.
Publicado: (2010)

Self-management in heart failure: where have we been and where should we go?
por: Gardetto, Nancy Jean
Publicado: (2011)

Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
por: Banz-Jansen, Constanze, et al.
Publicado: (2022)

Nurturing Holistic Development of University Students in Hong Kong: Where Are We and Where Should We Go?
por: Shek, Daniel T. L.
Publicado: (2010)

Pulse Crop Genetics for a Sustainable Future: Where We Are Now and Where We Should Be Heading
por: Sahruzaini, Nurul Amylia, et al.
Publicado: (2020)

Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC
por: Scarpa, Marco, et al.
Publicado: (2016)

Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease
por: Merigo, Flavia, et al.
Publicado: (2020)

The immune landscape of hepatocellular carcinoma-where we are?
por: Gryziak, Maciej, et al.
Publicado: (2022)

Pleuritic Chest Pain; Where Should We Search for?
por: Gharib, Behdad, et al.
Publicado: (2011)

Where and how the quark-gluon matter should be searched for?
por: Strugalski, Z
Publicado: (1997)

Video display during laparoscopy – where should it be placed?
por: Walczak, Dominik A., et al.
Publicado: (2014)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Durotaxis and negative durotaxis: where should cells go?
por: Ji, Congcong, et al.
Publicado: (2023)

Dietary Supplement for Core Symptoms of Autism Spectrum Disorder: Where Are We Now and Where Should We Go?
por: Li, Yong-Jiang, et al.
Publicado: (2017)

Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
por: Barros, Inês, et al.
Publicado: (2020)

The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
por: Kalampokas, Theodoros, et al.
Publicado: (2021)

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
por: Griffin, Morag, et al.
Publicado: (2020)

Altered Chemokine Signalling in Endothelial Progenitor Cells from Acute Ulcerative Colitis Patients
por: De Toni, L., et al.
Publicado: (2015)

RNA Dust: Where are the Genes?
por: Carninci, Piero
Publicado: (2010)

RNA Dust: Where are the Genes?
por: Carninci, Piero
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u0un6p4ne64m9kbfsethdelsjg